JY
ICCM icon

Jeff Yass’s IceCure Medical ICCM Stock Holding History

Jeff Yass’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-517
Closed -$8.6K – 12771
2023
Q3 		$8.6K Buy
+517
New +$16.3K ﹤0.01% 11735

Other funds holding ICCM

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Jeff Yass's ICCM Position: Q4 2023 in Review

Jeff Yass sold out of IceCure Medical (ICCM) in Q4 2023, closing a stake of 517 shares — an estimated $8.6K sold.

Jeff Yass first reported a position in ICCM in Q3 2023 and held it in 1 quarter. The position peaked at $8.6K in Q3 2023. 17 funds tracked by Wall St. Rank hold ICCM as of Q4 2023.

  • Jeff Yass reported no remaining IceCure Medical position as of Q4 2023 after selling out during the quarter.
  • Jeff Yass sold 517 IceCure Medical shares in Q4 2023, an estimated $8.6K.
  • Jeff Yass first reported a position in IceCure Medical in Q3 2023 and held it in 1 quarter.
  • Jeff Yass's IceCure Medical position peaked at $8.6K in Q3 2023.
  • 17 funds tracked by Wall St. Rank held IceCure Medical as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.